Logo CICANCER
Intranet Colaborate

Old CIC Events

Connecting the SASP, Innate Immune Signalling, and Lipid Metabolism in Oncogene-Induced Senescence 11/09/2025

Connecting the SASP, Innate Immune Signalling, and Lipid Metabolism in Oncogene-Induced Senescence

Juan Carlos Acosta Cobacho — IBBTEC , Santander

Defensa de la tesis doctoral: Functional Analysis of PCNA Deubiquitylation in Replication Fork Dynamics and Okazaki Fragment Maturation in Saccharomyces cerevisiae 18/07/2025

Defensa de la tesis doctoral: Functional Analysis of PCNA Deubiquitylation in Replication Fork Dynamics and Okazaki Fragment Maturation in Saccharomyces cerevisiae

Javier Zamarreño Lozano — Programa de doctorado de biociencias: biología y clínica de cáncer

Precision Biology for Precision Medicine: Cancer Genomics in Hematological Malignancies 17/07/2025

Precision Biology for Precision Medicine: Cancer Genomics in Hematological Malignancies

Xosé S. Puente — IUOPA-Universidad de Oviedo

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress. 14/07/2025

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress.

Cristian Prieto — IBCII - Univ. Frankfurt

RAS-PI3K signalling regulates myCAF phenotype acquisition to modulate tumour progression 10/07/2025

RAS-PI3K signalling regulates myCAF phenotype acquisition to modulate tumour progression

Marta Alcón — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies 07/07/2025

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies

Juan José Montero Valderrama — Institute of Molecular Oncology and Functional Genomics (IMO), Technical University of Munich (TUM). Munich

The long journey to develop a drug against an “undruggable” target in cancer 03/07/2025

The long journey to develop a drug against an “undruggable” target in cancer

Laura Soucek — Vall d´Hebron, Barcelona

Antibody-Drug Conjugates Targeting EGFR in Ovarian Cancer 30/06/2025

Antibody-Drug Conjugates Targeting EGFR in Ovarian Cancer

Sheila Almaraz — Centro de Investigación del Cáncer (Universidad de Salamanca - CSIC)

Structure of Centromeric Chromatin and Its Consequences for Genome Stability 19/06/2025

Structure of Centromeric Chromatin and Its Consequences for Genome Stability

Carlos Sacristán López — Hubrecht Institute, Utrech (Netherlands)

Metabolic Control of Cell Fate in Regeneration and Cancer 16/06/2025

Metabolic Control of Cell Fate in Regeneration and Cancer

Almudena Chaves Pérez — Memorial Sloan Kettering Cancer Centre (NY)

defensa de tesis: Unraveling the role of RNA modifications in immune evasion and tumor progression in prostate cancer 13/06/2025

defensa de tesis: Unraveling the role of RNA modifications in immune evasion and tumor progression in prostate cancer

Ana Macrina Añazco Guenkova — Programa de doctorado de biociencias: biología y clínica de cáncer

Dissecting metastatic Bladder Cancer 05/06/2025

Dissecting metastatic Bladder Cancer

Jesús M Paramio — CIEMAT and Inst Inv Biomed Univ Hosp “12 de Octubre”